Significant Ownership of Propel Bio Management, LLC
- Signature - Title
- Leen Kawas - Managing Member
- Location
- Los Angeles, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Propel Bio Management, LLC.
Follow Filing Activity
Follow Propel Bio Management, LLC and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Propel Bio Management, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc. | Common Stock | 9.9% | $21,001,011 | 8,861,186 | Propel Bio Management, LLC | 11 Jul 2025 | ||
| APLT | Applied Therapeutics, Inc. | Common Stock | 4.2% | $1,564,002 | 6,015,394 | Propel Bio Management, LLC | 29 Dec 2025 |
Schedules 13D/G Reported by Propel Bio Management, LLC:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.